Currently, there are a total of 66,132 registered beds in Malta and Gozo, with applications for a further 4,566 new beds. Of the total, 56,257 are located in Malta and 9,875 in Gozo.

The topic of registered beds has made headlines recently after the Malta Hotels and Restaurants Association commissioned big-four firm Deloitte to carry out a carrying capacity study for the island.

It found that if all hospitality projects in the pipeline get built, Malta will need to attract 4.7 million tourists a year by 2027, each staying just under seven nights, to prevent oversupply of accommodation becoming a serious issue.

Tourism Minister Clayton Bartolo has since said Malta has no intention of attracting those levels of tourist numbers. Indeed, 2019 was a record year with three million tourists having visited the island – still 1.7 million shy of the figure described in the MHRA study.

The number of current beds registered in Malta came to light through a parliamentary question submitted by Opposition speaker for tourism Robert Arrigo to Tourism Minister Clayton Bartolo.

The Minister was also asked for a number of beds found in establishments operating without a licence and whether new applications for hospitality establishments would be “stopped”.

Mr Bartolo said it was not possible to give a figure on unlicensed establishments however whenever one is found “they are being fined immediately and asked to regularise their position”.

He did not answer the Opposition speaker’s final question on whether new hospitality applications would be stopped for the time being.

Related

January 2023 surpasses pre-COVID figures for nights spent in Malta by tourists

March 20, 2023
by Arnas Lasys

For the first time, tourists spent over a million nights in Malta in January

The Single Market at 30 – tackling the EU’s long-term competitiveness

March 20, 2023
by Robert Fenech

The European Single Market accounts for 15% of global GDP

What does Malta offer the insurance industry?

March 18, 2023
by Robert Fenech

Malta has been at the forefront of the introduction of cell companies in the European Union